Pfizer Said to Pay $330 Million in Prempro Settlement

Pfizer Inc. agreed to pay about $330 million to resolve claims that its Prempro menopause drug caused breast cancer, in the first large-scale settlements in eight years of litigation, two people familiar with the accords said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.